An overview on the current status of cancer nanomedicines.

Nasimudeen R JabirKhalid AnwarChelapram K FirozMohammad OvesMohammad Amjad KamalShams Tabrez

Published in: Current medical research and opinion (2018)

In this review, we have summarized cancer nanomedicines (active and passive drug delivery) available in the market. We have also discussed other nanomedicines that are at different stages of clinical trials.

Keyphrases

papillary thyroid
clinical trial
drug delivery
current status
squamous cell
health insurance
childhood cancer
open label